塞力医疗
(603716)
| 流通市值：38.57亿 | | | 总市值：38.57亿 |
| 流通股本：2.26亿 | | | 总股本：2.26亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 342,777,079.75 | 181,793,715.24 | 1,076,955,608.35 | 857,205,461.5 |
| 营业总成本 | 393,612,619.03 | 195,176,452.61 | 1,168,127,783.62 | 925,431,549.78 |
| 其他经营收益 | | | | |
| 营业利润 | -58,049,104.47 | -19,923,521.06 | -147,090,026.04 | -80,483,168.62 |
| 利润总额 | -57,606,887.35 | -19,747,584.56 | -152,363,088.41 | -80,358,776.55 |
| 净利润 | -51,509,745.89 | -17,222,493.34 | -201,442,576.54 | -79,153,203.33 |
| 每股收益 | | | | |
| 其他综合收益 | -247,906.46 | -49,986.53 | -33,894,023.93 | -1,253,927.2 |
| 综合收益总额 | -51,757,652.35 | -17,272,479.87 | -235,336,600.47 | -80,407,130.53 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,025,533,268.12 | 1,166,530,243.81 | 1,238,366,074.58 | 1,381,721,482.71 |
| 非流动资产: | | | | |
| 非流动资产合计 | 565,221,123.54 | 572,955,568.73 | 564,077,183.48 | 708,634,798.12 |
| 资产总计 | 1,590,754,391.66 | 1,739,485,812.54 | 1,802,443,258.06 | 2,090,356,280.83 |
| 流动负债: | | | | |
| 流动负债合计 | 540,921,387.48 | 725,245,445.77 | 872,770,181.02 | 1,005,054,469.26 |
| 非流动负债: | | | | |
| 非流动负债合计 | 23,652,293.38 | 27,851,234.54 | 25,185,653.81 | 31,995,881.36 |
| 负债合计 | 564,573,680.86 | 753,096,680.31 | 897,955,834.83 | 1,037,050,350.62 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,092,356,151.52 | 1,026,293,953.22 | 944,688,922.95 | 1,091,110,657.57 |
| 股东权益合计 | 1,026,180,710.8 | 986,389,132.23 | 904,487,423.23 | 1,053,305,930.21 |
| 负债和股东权益合计 | 1,590,754,391.66 | 1,739,485,812.54 | 1,802,443,258.06 | 2,090,356,280.83 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 457,191,662.77 | 253,278,866.43 | 1,314,579,873.62 | 998,060,771.28 |
| 经营活动现金流出小计 | 491,975,269.92 | 267,677,476.12 | 1,352,331,876.35 | 1,022,660,285.44 |
| 经营活动产生的现金流量净额 | -34,783,607.15 | -14,398,609.69 | -37,752,002.73 | -24,599,514.16 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,646,396.96 | 4,561,588.96 | 89,361,936.5 | 61,047,772.08 |
| 投资活动现金流出小计 | 24,245,408.12 | 14,835,187.51 | 59,148,629.36 | 24,963,935.4 |
| 投资活动产生的现金流量净额 | -19,599,011.16 | -10,273,598.55 | 30,213,307.14 | 36,083,836.68 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 114,807,511.74 | 57,123,081.67 | 389,683,770.49 | 290,511,099.69 |
| 筹资活动现金流出小计 | 96,007,759.07 | 27,118,535.41 | 467,524,884.4 | 370,934,208.91 |
| 筹资活动产生的现金流量净额 | 18,799,752.67 | 30,004,546.26 | -77,841,113.91 | -80,423,109.22 |
| 汇率变动对现金及现金等价物的影响 | 803.25 | 1,681.63 | -649 | -36,940.48 |
| 现金及现金等价物净增加额 | -35,582,062.39 | 5,334,019.65 | -85,380,458.5 | -68,975,727.18 |
| 期末现金及现金等价物余额 | 86,521,963.03 | 127,438,045.07 | 122,104,025.42 | 138,508,756.74 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -35,582,062.39 | - | -85,380,458.5 | - |